McKesson revenues by business segment
Segment Revenues of McKesson 2017-2022
Amounts are in $millions.
| Year | US Pharmaceutical | International | Medical Surgical Solutions | Prescription Technology Solutions | Total |
| 2022 | $212,149 | $36,345 | $11,608 | $3,864 | $263,966 |
| 2021 | $189,274 | $35,965 | $10,099 | $2,890 | $238,228 |
| 2020 | $181,700 | $38,341 | $8,305 | $2,705 | $231,051 |
| 2019 | $166,189 | $38,023 | $7,618 | $2,489 | $214,319 |
2022: The business of McKesson Corporation is divided into four major segments that include US Pharmaceutical, International, Medical Surgical solutions, and prescription technology solutions. US pharmaceutical is the largest business segment of the company based on net revenues. In fiscal 2022, the company generated $212,149 million in net sales from the US Pharmaceutical segment compared to $189,274 million in 2021. Its net sales from the international segment increased to $36,345 million in 2022 compared to $35,965 million in 2021.
| Year | U.S. Pharmaceutical and Specialty Solutions | European Pharmaceutical Solutions | Medical-Surgical Solutions | Other | Total |
| 2019 | $167,763 | $27,242 | $7,618 | $11,696 | $214,319 |
| 2018 | $162,587 | $27,320 | $6,611 | $11,839 | $208,357 |
| 2017 | $155,236 | $24,847 | $6,244 | $12,206 | $198,533 |